A new investigational toothpaste, INT301, developed by New York-based biotech firm Intrommune, shows promise in treating adults with peanut allergies. The toothpaste, which exposes the body to increasingly tiny amounts of peanut protein, met its safety goals in a 4-month trial involving 32 adults. All participants tolerated the highest dose, with only mild itching reported as a reaction. Further trials will explore the toothpaste’s effectiveness in helping to desensitize adults to peanut protein.
Bootkitty is the first UEFI Bootkit designed for Linux systems
Cybersecurity researchers from ESET identified the first-ever UEFI bootkit for Linux systems, known as Bootkitty. The bootkit targets the system’s signature verification feature, disabling it